Mineralys Therapeutics, Inc. (MLYS)
Healthcare
Biotechnology
25.50 $
-2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Mineralys Therapeutics, Inc. (MLYS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -39 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -19 | -29 | -19 | -30 | -50 | -67 | -45 | -30 | -29 | -38 | -39 | -136 | |
| 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 1.3 | 1.6 | 1.5 | 2.2 | 0.0 | 3.1 | 3.1 | 3.6 | 4.6 | 5.8 | 5.3 | 6.5 | 22 | |
| -0.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -7.5 | 4.1 | -4.0 | 13 | 11 | 5.7 | -20 | -5.9 | 11 | 4.6 | -6.7 | -2.1 | 6.6 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -16 | 4.0 | -8.1 | -56 | 7.7 | 80 | 84 | -93 | -43 | -151 | -103 | -45 | -342 | |
| 0.0 | – | 0.1 | – | – | 0.1 | – | – | 0.1 | – | 0.1 | – | – | |
| -0.6 | 0.2 | 0.1 | 116 | -0.2 | 0.0 | 0.1 | 189 | 9.8 | 295 | 97 | 24 | 426 | |
| -37 | -15 | -37 | 41 | -23 | 29 | 17 | 51 | -63 | 116 | -45 | -60 | -52 | |
| -20 | -19 | -29 | -19 | -30 | -50 | -67 | -45 | -30 | -29 | -38 | -39 | -136 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.